Dose-response Curves: Psychopharmacology Considerations
About the Lecture
The lecture Dose-response Curves: Psychopharmacology Considerations by Melissa Kalensky, FNP-BC, PMHNP-BC, CNE is from the course Psychopharmacology Foundations: From Pharmacokinetics to Clinical Practice.
Included Quiz Questions
What characteristic curve shape do many psychotropic medications exhibit in their dose-response relationship?
- Bell-shaped curve.
- Linear ascending curve.
- Exponential growth curve.
- Inverted U-shaped curve.
- Plateau curve.
How do psychotropic medications primarily differ from other drug classes, such as blood pressure medications, in their dose-response characteristics?
- They often show decreased effectiveness at higher doses.
- They always require higher doses for better effects.
- They have more predictable linear responses.
- They work faster at all dose ranges.
- They have fewer side effects overall.
What happens to many psychotropic medications when doses are increased beyond the optimal therapeutic range?
- Therapeutic effectiveness may decrease despite higher doses.
- Therapeutic effectiveness continues to increase proportionally.
- Side effects disappear completely.
- The medication becomes more selective.
- The onset of action becomes faster.
Which characteristic requires careful monitoring for medications with narrow therapeutic windows?
- Small difference between effective and toxic doses.
- Large safety margin between doses.
- Predictable patient response patterns.
- Minimal drug interaction potential.
- Long elimination half-lives.
How can medication side effects be strategically used for therapeutic benefit?
- By selecting medications whose side effects address comorbid conditions.
- By increasing doses until side effects become therapeutic.
- By combining multiple medications with similar side effects.
- By timing doses to maximize side effect occurrence.
- By using side effects to replace primary therapeutic effects.
These courses may be of interest to you
Author of lecture Dose-response Curves: Psychopharmacology Considerations
Melissa Kalensky, FNP-BC, PMHNP-BC, CNE
Customer reviews
5,0 of 5 stars
| 5 Stars |
|
5 |
| 4 Stars |
|
0 |
| 3 Stars |
|
0 |
| 2 Stars |
|
0 |
| 1 Star |
|
0 |
